首页> European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)> A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy

A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy

导出原文传递

翻译打印收藏纠错

第一作者： Choi, In Sil

作者： Choi, In Sil ^[1] ; Kim, Ki Hwan ^[2] ; Lee, Ju Hyun ; Suh, Koung Jin ; Kim, Ji-Won ; Park, Jin Hyun ; Kim, Yu Jung ; Kim, Jin-Soo ; Kim, Jee Hyun ; Kim, Jin Won

作者单位： Boramae Med Ctr,Seoul Natl Univ ^[1] Bundang Hosp,Seoul Natl Univ ^[2]

关键词 Biliary tract cancer mFOLFOX mFOLFIRI Second-line chemotherapy OPEN-LABEL CHOLANGIOCARCINOMA MULTICENTER

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

European journal of cancer

2021年154卷

288-295页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

点击下载本期目录封面

European journal of cancer

2021年154卷

288-295页

检索历史清除

A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy

European journal of cancer

相似文献

同项目论文

European journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy

European journal of cancer

相似文献

同项目论文

European journal of cancer

相关期刊

检索历史清除